Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties.

In this issue, CEO Karin Bryder comments on that Apoteket AB will begin to offer the company’s product Efemia Bladder Support at 33 pharmacies in Sweden, including in Stockholm, Gothenburg and Malmö, and that the product will soon be possible to get on prescription in five healthcare regions in Sweden.

To read the newsletter, and subscribe to receive upcoming issues, follow this link:

The newsletter is published in Swedish and English, with a flexible publishing frequency based on Invent Medic’s news flow. It is produced together with the company’s IR communication partner Honeybadger, Invent Medic encourages feedback and requests on topics for upcoming issues of the newsletter.

Download: Release